A Dx Puzzle is Solved: Beckman Acquires Hybritech
Executive Summary
Eli Lilly’s sale of Hybritech to Beckman Instruments marks the end of the pharmaceutical company’s rocky foray into diagnostics.You may also be interested in...
Beckman Coulter's Play for High Growth
With the Coulter integration successful, Beckman Coulter looks for high-growth opportunities outside of its traditional businesses. Beckman, through internal efforts in its life sciences business and a series of small alliances, is making a play in genomics and proteomics. In addition to building up near-term revenues, the aim is to find new "content" in the form of assays for its clinical business.
Cybersecurity: Guidance Docs To Come, But Legacy Devices Still A Challenge
Increasing savvy around cybersecurity issues is driving regulators and trade groups to update their approach to the area, speakers from the US FDA and the American Medical Association said at this week’s FDA/CMS Summit.
Majority Of Spanish OTC Firms Investing Heavily In Digital
A recent ANEFP survey shows that the majority of Spanish OTC firms consider their digital strategies to be "very advanced."
Existing Subscriber?
Sign in to continue reading.
Need a specific report? 1000+ reports available
Buy Reports
Need a specific report? 1000+ reports available
Buy Reports